| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.48 | 0.003 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |